In a remarkable financial turn, Torrent Pharmaceuticals has disclosed a staggering 30% rise in after-tax profit for the September quarter, reaching ₹591 crore. This impressive growth is attributed to thriving sales in various markets, which escalated their total revenue to ₹3,302 crore.
Sebi imposes Rs 10 lakh fine on Anand Rathi for violation of stock brokers’ norms
India’s market regulator Sebi fined Anand Rathi Share and Stock Brokers ₹10 lakh after inspections found multiple regulatory violations, including delayed glitch reporting, excessive capacity